Page 137 - 202016

[ 7 ] 毕晓东，陈日新，许丛丛，等.白癜风患者100例甲病变发 JAK-inhibitors[J]. J Dermatol Treat，2017，29（1）：98-99.
生率分析[J].中国皮肤性病学杂志，2020，34（4）：405- [19] MOK CC. The jakinibs in systemic lupus erythematosus：
408. progress and prospects[J]. Expert Opin Inv Drug，2018，28
[ 8 ] JOWKAR F，GODARZI H，PARVIZI MM. Can we con- （1）：85-92.
sider silymarin as a treatment option for vitiligo： a [20] XING L，DAI Z，JABBARI A，et al. Alopecia areata is
double-blind controlled randomized clinical trial of driven by cytotoxic T lymphocytes and is reversed by
phototherapy plus oral silybum marianum product versus JAK inhibition[J]. Nat Med，2014，20（9）：1043-1049.
phototherapy alone[J]. J Dermatol Treat，2019，31（3）： [21] SAMAKA RM，BASHA MA，MENESY D. Role of Janus
256-260. kinase 1 and signal transducer and activator of trans-
[ 9 ] ORTIZ-IBÁÑEZ K，ALSINA MM，MUÑOZ-SANTOS C. cription 3 in vitiligo[J]. Clin Cosmet Investig Dermatol，
Tofacitinib and other kinase inhibitors in the treatment of 2019. DOI：10.2147/CCID.S210106.
psoriasis[J]. Act Derm，2013，104（4）：304-310. [22] NADA HR，EL SHARKAWY DA，ELMASRY MF，et al.
[10] JABBARI A，SANSARICQ F，CERISE J，et al. An open- Expression of Janus kinase 1 in vitiligo & psoriasis before
label pilot study to evaluate the efficacy of tofacitinib in and after narrow band UVB：a case control study[J]. Arch
moderate to severe patch-type alopecia areata，totalis，and Dermatol Res，2017，310（1）：39-46.
universalis[J]. J Invest Dermatol，2018，138（7）：1539- [23] 张霞，章国龙. 托法替尼的结构鉴定与构象分析[J].中国
1545. 现代应用药学，2019，36（5）：542-544.
[11] HUANG YW，TSAI TF. Remission duration and long- [24] SUZUKI M，SHOJI S，MIYOSHI S，et al. Model based
term outcomes in patients with moderate-to-severe psori- comparison of dose response profiles of tofacitinib in
asis treated by biologics or tofacitinib in controlled japanese versus western rheumatoid arthritis patients[J]. J
clinical trials：a 15-year single-center experience[J]. Clin Pharmacol，2019，60（2）：198-208.
Dermatol Ther，2019，9（3）：553-569. [25] KIM BS，SUN K，PAPP K，et al. Effects of ruxolitinib
[12] PUROHIT VS，PORTS WC，WANG C，et al. Systemic cream on pruritus and quality of life in atopic dermatitis：
tofacitinib concentrations in adult patients with atopic Results from a phase 2，randomized，dose-ranging，
dermatitis treated with 2％ tofacitinib ointment and vehicle- and active-controlled study[J]. J Am Acad
application to pediatric study planning[J]. J Clin Dermatol，2020，82（6）：1305-1313.
Pharmacol，2018，59（6）：811-820. [26] 岳燕，师晓东.鲁索利替尼挽救性治疗激素难治性或复发
[13] CRAIGLOW BG，KING BA. Tofacitinib citrate for the 的儿童移植物抗宿主病的临床观察[J].中国小儿血液与
treatment of vitiligo[J]. JAMA Dermatology，2015，151 肿瘤杂志，2018，23（4）：211-216、224.
（10）：1110-1112. [27] 谢旭磊，杨圣俊，郝洪岭，等. SOCS1、SHP1在JAK2V617F
[14] HARRIS JE，RASHIGHI M，NGUYEN N，et al. Rapid 突变阳性骨髓增殖性肿瘤中的表达及鲁索替尼的调控
skin repigmentation on oral ruxolitinib in a patient with 作用[J].第二军医大学学报，2018，39（1）：74-80.
coexistent vitiligo and alopecia areata （AA）[J]. J Am [28] VU M，HEYES C，ROBERTSON SJ，et al. Oral tofa-
Acad Dermatol，2016，74（2）：370-371. citinib：a promising treatment in atopic dermatitis，
[15] LILIANA G，ELENA D，SERENA B，et al. Vitiligo： alopecia areata and vitiligo[J]. Clin Exp Dermatol，2017，
pathogenetic hypotheses and targets for current 42（8）：942-944.
therapies[J]. Curr Drug Metab，2010，11（5）：451-467. [29] ALMUTAIRI N，NOUR TM，HUSSAIN NH. Janus kin-
[16] HARRIS JE，HARRIS TH，WENINGER W，et al. A ase inhibitors for the treatment of severe alopecia areata：
mouse model of vitiligo with focused epidermal depig- an open-lasel comparative study[J]. Dermatology，2019，
+
mentation requires IFN-γ for autoreactive CD8 T-cell 235（2）：130-136.
accumulation in the skin[J]. J Invest Dermatol，2012，132 [30] ROTHSTEIN B，JOSHIPURA D，SARAIYA A，et al.
（7）：1869-1876. Treatment of vitiligo with the topical Janus kinase
[17] RASHIGHI M，AGARWAL P，RICHMOND JM，et al. inhibitor ruxolitinib[J]. J Am Acad Dermatol，2017，76
CXCL10 is critical for the progression and maintenance （6）：1054-1060.
of depigmentation in a mouse model of vitiligo[J]. Sci [31] 白癜风最具潜力药物：鲁索替尼的最新消息[EB/OL].
Transl Med，2014. DOI：10.1126/scitranslmed.3007811. （2020-01-22）[2020-05-26]. http：//www.360doc.com/
[18] JOSHIPURA D，PLOTNIKOVA N，GOLDMINZ A，et al. content/20/0122/09/1086806_887418139.shtml.
Importance of light in the treatment of vitiligo with [32] 黄世杰.鲁索替尼乳膏剂治疗白癜风的Ⅲ期临床试验首

中国药房 2020年第31卷第16期 China Pharmacy 2020 Vol. 31 No. 16 ·2047 ·